Mutual of America Capital Management LLC Sells 12,816 Shares of Tenet Healthcare Co. (NYSE:THC)

Mutual of America Capital Management LLC lowered its holdings in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 11.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,059 shares of the company's stock after selling 12,816 shares during the period. Mutual of America Capital Management LLC owned approximately 0.10% of Tenet Healthcare worth $7,335,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. US Bancorp DE raised its position in shares of Tenet Healthcare by 14.6% in the 1st quarter. US Bancorp DE now owns 1,428 shares of the company's stock worth $123,000 after purchasing an additional 182 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Tenet Healthcare by 46.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 629 shares of the company's stock worth $31,000 after buying an additional 199 shares in the last quarter. Treasurer of the State of North Carolina grew its holdings in shares of Tenet Healthcare by 0.5% during the third quarter. Treasurer of the State of North Carolina now owns 44,328 shares of the company's stock valued at $2,921,000 after buying an additional 220 shares during the last quarter. Rockefeller Capital Management L.P. raised its holdings in Tenet Healthcare by 0.5% in the 2nd quarter. Rockefeller Capital Management L.P. now owns 44,692 shares of the company's stock worth $3,637,000 after acquiring an additional 243 shares during the last quarter. Finally, Cetera Investment Advisers lifted its position in Tenet Healthcare by 4.3% in the 4th quarter. Cetera Investment Advisers now owns 6,111 shares of the company's stock valued at $298,000 after acquiring an additional 253 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.

Tenet Healthcare Price Performance

Shares of THC traded down $1.38 during trading hours on Friday, hitting $100.44. 898,660 shares of the stock were exchanged, compared to its average volume of 914,019. Tenet Healthcare Co. has a 12-month low of $51.04 and a 12-month high of $107.80. The company has a debt-to-equity ratio of 4.77, a quick ratio of 1.42 and a current ratio of 1.51. The stock's 50-day moving average price is $96.79 and its two-hundred day moving average price is $78.26. The company has a market cap of $10.04 billion, a price-to-earnings ratio of 17.59, a price-to-earnings-growth ratio of 3.19 and a beta of 2.08.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Thursday, February 8th. The company reported $2.68 EPS for the quarter, topping analysts' consensus estimates of $1.58 by $1.10. Tenet Healthcare had a return on equity of 26.34% and a net margin of 2.97%. The firm had revenue of $5.38 billion for the quarter, compared to the consensus estimate of $5.28 billion. During the same quarter last year, the business posted $1.96 earnings per share. The firm's revenue was up 7.8% compared to the same quarter last year. Research analysts expect that Tenet Healthcare Co. will post 6.09 earnings per share for the current year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Richard J. Mark sold 14,000 shares of the firm's stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $98.98, for a total transaction of $1,385,720.00. Following the completion of the sale, the director now owns 33,303 shares in the company, valued at approximately $3,296,330.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Richard W. Fisher sold 2,100 shares of the stock in a transaction on Wednesday, February 14th. The stock was sold at an average price of $88.21, for a total value of $185,241.00. Following the sale, the director now directly owns 20,127 shares in the company, valued at $1,775,402.67. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard J. Mark sold 14,000 shares of the company's stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $98.98, for a total value of $1,385,720.00. Following the sale, the director now owns 33,303 shares in the company, valued at approximately $3,296,330.94. The disclosure for this sale can be found here. Insiders have sold 51,268 shares of company stock worth $4,944,810 in the last ninety days. 1.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Truist Financial upped their price target on Tenet Healthcare from $92.00 to $105.00 and gave the company a "buy" rating in a report on Friday, February 9th. TheStreet upgraded Tenet Healthcare from a "c+" rating to a "b-" rating in a research note on Tuesday, February 6th. Deutsche Bank Aktiengesellschaft raised their price target on Tenet Healthcare from $100.00 to $126.00 and gave the company a "buy" rating in a report on Friday. Cantor Fitzgerald restated an "overweight" rating and set a $104.00 target price on shares of Tenet Healthcare in a research report on Wednesday. Finally, Wells Fargo & Company boosted their price target on shares of Tenet Healthcare from $105.00 to $115.00 and gave the stock an "overweight" rating in a research report on Thursday, March 28th. One analyst has rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $100.38.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.